Svar Life Science

Svar Life Science Providing Answers – It’s in Their Name. Did you know that Svar means Answers in Swedish? The company offers state-of-the-art products, versatile assay solutions, and services to aid clients in obtaining the necessary answers for drug development or basic research projects.

With extensive experience in assay development, bioanalysis, and clinical diagnostics, Svar Life Science emerges as an ideal partner for pharma, biotech, and CROs.

The company also furnishes tools for diagnosing, prognosing, and monitoring inflammatory and related diseases, supplying physicians with the essential answers to administer appropriate treatments at the right time.

Whether contributing to new drug development or disease diagnosis, Svar Life Science is committed to assisting in obtaining the answers needed.

Life science is continually posing new questions. It's an integral part of the discovery process. As the field progresses, innovative tools and techniques surface, demanding stable and reliable solutions. Svar Life Science steps in to identify the right techniques and generate robust data.

Svar Life Science, a Swedish group of companies, specializes in inventing, developing, and applying cutting-edge assay technology for drug development and clinical diagnostics. The company aims to deliver tailored solutions, establish practical platforms for routine clinical testing, and share knowledge to enhance competencies through partnerships.

With over 30 years of experience in the clinical diagnostic value chain, Svar Life Science excels in autoimmunity, inflammatory diseases, and oncology. It offers customized cell-based and immunoassays for biopharma companies and clinical labs worldwide, covering the entire drug development value chain from discovery to clinical phases.

The company's contribution extends to providing tools for effective patient diagnosis and monitoring, pushing boundaries in drug discovery and diagnostics to enhance patient care.

Off-the-Shelf Products

Svar Life Science specializes in complement system assessment, the development of cell-based assays, and innovative calprotectin solutions.

Their expansive life science product portfolio supports drug development, disease management, and diagnosis. Immunoassays and Mechanism of Action (MoA) cellular assays cater to all phases of drug development, serving commercial labs, research facilities, and clinical diagnostics.

CRO Services

The company offers extensive bioanalytical services and in-house products to streamline the drug development process.

Their customer-centric approach supports Bioanalytical Services, Biomarker Discovery Services, and QC Testing Services, ensuring collaborative excellence in every project within their GxP-compliant lab.

Custom Solutions

Svar Life Science specializes in designing personalized and reliable solutions for assay development and production needs when standard products fall short.

Services include assay-ready cell development, the establishment of master cell banks, and the opportunity to develop and optimize a tailored cell line for specific targets.

Diagnostic Testing Services

The company's diagnostic services encompass a comprehensive range, providing individual clinical diagnostic tests, test panels, urgent testing, and therapeutic drug monitoring globally to clinicians and laboratories.

Diagnostic Testing Services cover clinical routine testing, therapeutic drug monitoring, and collaboration for laboratory research, reflecting the company's commitment to advancing scientific discovery through expertise and cutting-edge technologies.

Subsidiaries

Svar Life Science's subsidiaries complement and enhance its core business, integral to the company's vision of leading the development of tomorrow's life science solutions and serving the global life science market with tools for drug development and companion diagnostics solutions.

Wieslab AB

Wieslab, a part of Svar Life Science in Malmö, Sweden, specializes in delivering diagnostic laboratory services with a focus on neuro-immunology, nephrology, rheumatology, and gastroenterology.

Wieslab Diagnostic Services is committed to providing high-quality, fast laboratory services, offering one of the most comprehensive autoimmune testing services worldwide.

Quality is at the core of operations, being among the first private laboratories accredited by SWEDAC and adhering to ISO 15189 standards, as well as the Swedac Good Laboratory Practice (GLP) program.

The ultimate aim is to provide laboratory and clinical physicians with a reliable decision-making basis for patient treatment, offering fast and precise results.

Calpro AS

Calpro AS, a Norwegian biotech company and part of Svar Life Science, is a leading force in the research and development of Calprotectin-based diagnostic tests.

Specializing in harnessing the potential of this unique biomarker, Calpro AS aims to transform diagnostics. Calprotectin, constituting about 60% of the cytosol of Neutrophils, plays a crucial role in diagnosing inflammatory bowel disease (IBD) and tracking patient progress.

Calpro AS is committed to revolutionizing IBD patient care with E-Health, an emerging technology providing objective data to healthcare providers, offering immense benefits in reducing heavy medications, emergency admissions, surgeries, and costly treatments.

Company History

Svar Life Science, with a legacy of innovation and excellence spanning nearly three decades, has been instrumental in assay solution development for the global life science market.

Rooted in a strong Scandinavian heritage, the company is dedicated to delivering high-quality, responsive services. Key milestones include the 2018 transformation of Euro Diagnostica into Svar Life Science, marking a commitment to answers and a key position in the dynamic life science sector.

Notable acquisitions include joining forces with Calpro AS in 2017, the 2014 expansion with the acquisition of Biomonitor A/S, and expertise enhancement through the 2011 acquisition of Vita Diagnostika GmbH.

Milestones like the 2007 introduction of the CCPoint assay and the groundbreaking 2002 Anti-CCP2 assay highlight the dedication to revolutionizing diagnostics. Svar Life Science's journey began in 1992, offering assay solutions and evolving to serve the life science community while staying true to its Scandinavian heritage.

Today, Svar Life Science stands as a testament to dedication in advancing healthcare through cutting-edge solutions and collaborative partnerships.

Search for products by Svar Life Science